Literature DB >> 12706871

Ceramide induces cell cycle arrest and upregulates p27kip in nasopharyngeal carcinoma cells.

Xiao-Feng Zhu1, Zong-Chao Liu, Bin-Fen Xie, Gong-Kan Feng, Yi-Xin Zeng.   

Abstract

Ceramide mediates differentiation, growth arrest, apoptosis, proliferation, cytokine biosynthesis and secretion, and a variety of other cellular functions. However, little is known regarding ceramide signaling linked to the cell cycle. In the present study, the effect of ceramide on cell cycle in nasopharyngeal carcinoma cell line CNE2 was investigated. The results showed that ceramide inhibited cell proliferation and induced cell cycle arrest in G1 phase in CNE2 cells. Exposure of CNE2 cells to ceramide resulted in a dose-dependent up-regulation of the cyclin-dependent kinase inhibitor p27 and a decrease of phospho-Akt without reduced expression of total AKT protein. The activation of phosphatidylinositol-3-kinase (PI3K) and the protein expression of PTEN were unaffected following ceramide treatment. We concluded that ceramide induced cell cycle arrest in G1 phase in CNE2 cells and p27 up-regulation was involved in this process. In addition, up-regulation of p27 resulting from ceramide treatment may be due to the interruption of Akt, but decrease of phospho-Akt is independent of PI3K function or PTEN protein expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706871     DOI: 10.1016/s0304-3835(03)00050-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections.

Authors:  Curtis J Pritzl; Young-Jin Seo; Chuan Xia; Madhuvanthi Vijayan; Zachary D Stokes; Bumsuk Hahm
Journal:  J Immunol       Date:  2015-03-25       Impact factor: 5.422

Review 2.  Ceramide induced mitophagy and tumor suppression.

Authors:  Mohammed Dany; Besim Ogretmen
Journal:  Biochim Biophys Acta       Date:  2015-01-26

3.  PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.

Authors:  Shyam Babu Prasad; Suresh Singh Yadav; Mitali Das; Arusha Modi; Soni Kumari; Lakshmi Kant Pandey; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  Cell Oncol (Dordr)       Date:  2015-03-28       Impact factor: 6.730

4.  Protection by D609 through cell-cycle regulation after stroke.

Authors:  Rao Muralikrishna Adibhatla; James F Hatcher
Journal:  Mol Neurobiol       Date:  2010-02-12       Impact factor: 5.590

Review 5.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

6.  [Novel tumor metastasis suppressorgene LASS2/TMSG1 S248A mutant promotes invasion of prostate cancer cells through increasing ATP6V0C expression].

Authors:  K G Zhang; Y H Zhou; Y K Shao; F Mei; J F You; B Y Liu; F Pei
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-18

Review 7.  Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis.

Authors:  Erhard Bieberich
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 8.  A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.

Authors:  Tarek A Taha; Thomas D Mullen; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2006-11-01

9.  Long-term administration of red ginseng non-saponin fraction rescues the loss of skeletal muscle mass and strength associated with aging in mice.

Authors:  Da-Eun Cho; Gwang-Muk Choi; Yong-Seok Lee; Joon-Pyo Hong; Mijung Yeom; Bombi Lee; Dae-Hyun Hahm
Journal:  J Ginseng Res       Date:  2021-12-16       Impact factor: 5.735

Review 10.  Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance.

Authors:  Antonia Piazzesi; Sumaiya Yasmeen Afsar; Gerhild van Echten-Deckert
Journal:  Mol Oncol       Date:  2021-07-29       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.